Nilanjana Basu is a correspondent specializing in local business news in India. She writes for Seeking Alpha and her work has also appeared in exchange4media. Nilanjana covers a wide range of topics including corporate appointments, financial announcements, and market updates.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Nilanjana's focus is on local Indian coverage of financial results, stock market movements, and company news. She often cites data and press releases but also includes expert commentary. Given the heavy emphasis on financial results and stock market movements, pitches related to in-depth analysis of corporate performance within the Indian context would likely resonate with her. Moreover, she may be receptive to interviews or insights from experts who can provide valuable perspectives on sales & marketing strategies or industry partnerships within India.
It's essential for sources reaching out to Nilanjana Basu to have a strong understanding of the Indian business landscape and its specific nuances when it comes to financial reporting, as this aligns with her primary areas of interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Nilanjana Basu
NewAmsterdam Pharma Company N.V. (NAMS) announces a $300M public offering of ordinary shares and pre-funded warrants, with an option for additional shares.
ONGold Resources ( TSXV: ) intends to complete a non-brokered flow-through private placement offering for aggregate gross proceeds of up to $3M.
By: Nilanjana Basu
PennantPark Floating Rate Capital to expand investment in PennantPark Senior Secured Loan Fund with $100 million capital increase, boosting total capacity...
Ciena Corporation (CIEN) shares surge after beating revenue expectations with strong AI growth.
Washington Trust Bancorp announces a $55M public offering of common stock with an option for additional shares.
Hancock Whitney Corporation announces stock buyback program allowing purchase of up to 5% of outstanding shares from 2025-2026.
By: Nilanjana Basu
Digihost Technology (NASDAQ:DGHI) and NANO Nuclear Energy Inc.
Dyne Therapeutics (DYN) receives an Outperform rating from Baird for its potential in treating myotonic dystrophy type 1, with a $46 price target.
By: Nilanjana Basu
A weekly summary of insider trading highlighting notable buying and selling by investors, directors and executives. The trades have taken place between December 9 and December 13, 2024.
By: Nilanjana Basu
Analysis of short interest for healthcare stocks in S&P 500 in November.
(833) 317-6278 
